Detalles de la búsqueda
1.
Support, not blame: safe partner disclosure among women diagnosed with HIV late in pregnancy in South Africa and Uganda.
AIDS Res Ther
; 21(1): 14, 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481233
2.
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 75(1): e525-e528, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271729
3.
Oral versus Intravenous Antibiotics for Bone and Joint Infection.
N Engl J Med
; 380(5): 425-436, 2019 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30699315
4.
'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
BMC Pregnancy Childbirth
; 22(1): 566, 2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840939
5.
"It's only fatness, it doesn't kill": a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda.
BMC Womens Health
; 22(1): 246, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729541
6.
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy.
AIDS Res Ther
; 19(1): 24, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672853
7.
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.
Clin Infect Dis
; 73(5): e1200-e1207, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33346335
8.
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
J Antimicrob Chemother
; 76(12): 3286-3295, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34450619
9.
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda.
BMC Public Health
; 20(1): 1883, 2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33287795
10.
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda.
BMC Health Serv Res
; 20(1): 705, 2020 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738918
11.
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
PLoS Med
; 16(9): e1002895, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31539371
12.
Cardiovascular disease, medication regimens and HIV in pregnancy: new research relevant to nurses.
Br J Nurs
; 33(11): S18-S21, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850141
13.
Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy.
Clin Infect Dis
; 61(12): 1825-30, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270682
14.
Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravir.
J Antimicrob Chemother
; 70(2): 550-4, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25261424
15.
A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells.
J Pharm Biomed Anal
; 245: 116155, 2024 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38652938
16.
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV.
AIDS
; 38(7): 975-981, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277390
17.
A scoping review of Clinical Studies, Hospital Group Reports and National Strategic Documents on vascular access devices in cancer patients.
J Vasc Access
; 24(4): 575-590, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473000
18.
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MS.
Bioanalysis
; 15(13): 739-756, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293769
19.
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma.
J Pharm Biomed Anal
; 233: 115436, 2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148698
20.
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet Infect Dis
; 23(2): 183-195, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36272432